glutamic acid has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 11 (44.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 4 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Chai, Z; Chen, YY; Ding, ZB; Han, QX; He, Y; Ma, CG; Song, LJ; Wang, Q; Xiao, BG; Yin, JJ; Yu, JZ | 1 |
| Bhatt, JM; Dravid, SM; Gakare, SG; Narasimhan, KKS | 1 |
| Bakhtiyarova, KZ; Kuzmina, US; Vakhitov, VA; Vakhitova, YV; Zainullina, LF | 1 |
| Heo, H; Kim, JK; Kim, KW; Lee, DH; Lee, DW; Woo, DC | 1 |
| Heo, H; Kim, JK; Kim, KW; Lee, DH; Lee, DW; Woo, CW; Woo, DC | 1 |
| Atlasi, MA; Azami Tameh, A; Beyer, C; Clarner, T; Hassanzadeh, G; Naderian, H | 1 |
| Bossu, JL; Doussau, F; Dupont, JL; Gaillard, S; Heid, F; Isope, P; Pauillac, S; Popoff, MR; Poulain, B; Wioland, L | 1 |
| Bernardi, G; Centonze, D; Furlan, R; Martino, G; Muzio, L; Rossi, S | 1 |
| Casaccia, P; Dietz, K; He, Y; Howell, O; Kim, JY; Reynolds, R; Shen, S | 1 |
| Carlson, NG; Hill, KE; Redd, JW; Rojas, MA; Rose, JW; Tang, P; Wood, B | 1 |
| Chatterjee, S; Kesavadas, C; Saini, J; Thomas, B | 1 |
| Cogo, MG; Frigeni, B; Frigo, M; Fusco, ML; Gardinetti, M | 1 |
| Ben-Hur, T; Grigoriadis, N; Karussis, D; Milonas, I | 1 |
| Anhuf, D; Häusler, M; Möller-Hartmann, W; Ramaekers, VT; Schüler, H; Thron, A; Zerres, K | 1 |
| Domercq, M; Etxebarria, E; Matute, C; Pérez-Samartín, A | 1 |
| Alevra, X; Christodoulou, K; Georgiou, DM; Hadjisavvas, A; Kleopa, KA; Kyriakides, T; Nicolaou, P; Zamba-Papanicolaou, E | 1 |
| Cianfoni, A; Imbesi, SG; Niku, S | 1 |
| Auberson, M; Blanz, J; Hübner, CA; Jentsch, TJ; Maier, H; Muenscher, A; Schweizer, M | 1 |
| Capello, E; Cavalla, P; Giordana, MT; Mancardi, GL; Merola, A; Mutani, R; Piacentino, C; Vercellino, M; Votta, B | 1 |
| Li, SJ; Prost, R; Rand, SD | 1 |
| Domercq, M; Fogarty, DJ; Matute, C; Pascual de Zulueta, M; Sánchez-Gómez, MV | 1 |
| Blüml, S; Hwang, JH; Moreno, A; Ross, BD | 1 |
| Matute, C; Pérez-Cerdá, F | 1 |
| Alberdi, E; Domercq, M; Matute, C; Pérez-Cerdá, F; Pérez-Samartín, A; Sánchez-Gómez, MV | 1 |
| Bisaga, GN; Odinak, MM; Pozdniakov, AV; Tiutin, LA | 1 |
7 review(s) available for glutamic acid and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
[The role of glutamate in the pathogenesis of multiple sclerosis].
Topics: Demyelinating Diseases; Endothelial Cells; Glutamic Acid; Humans; Multiple Sclerosis; Oligodendroglia | 2019 |
The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
Topics: Animals; Cytokines; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Glutamic Acid; Inflammation; Multiple Sclerosis; Nerve Degeneration; Synaptic Transmission | 2010 |
Glutamate and multiple sclerosis.
Topics: Animals; Central Nervous System; Demyelinating Diseases; Glutamic Acid; Humans; Multiple Sclerosis; Oxidative Stress | 2012 |
Axonal damage in multiple sclerosis: a complex issue in a complex disease.
Topics: Adjuvants, Immunologic; Axons; Brain; Demyelinating Diseases; Diagnosis, Differential; Glutamic Acid; Humans; Interferon-beta; Macrophages; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Nerve Degeneration | 2004 |
Proton MR spectroscopy of the brain.
Topics: Brain; Brain Abscess; Brain Diseases; Brain Neoplasms; Carbon Isotopes; Cerebral Infarction; Demyelinating Diseases; Diagnosis, Differential; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Membrane Lipids; Multiple Sclerosis; Neurotransmitter Agents; Phosphorus Isotopes; Protons; United States; United States Food and Drug Administration | 1999 |
On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS.
Topics: Animals; Cell Communication; Central Nervous System; Central Nervous System Diseases; Demyelinating Diseases; Glutamic Acid; Homeostasis; Humans; Synapses | 1999 |
The link between excitotoxic oligodendroglial death and demyelinating diseases.
Topics: Animals; Autoimmunity; Cell Death; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; GluK2 Kainate Receptor; Glutamic Acid; Humans; Multiple Sclerosis; Neurotoxins; Oligodendroglia; Optic Nerve; Receptors, AMPA; Receptors, Kainic Acid | 2001 |
18 other study(ies) available for glutamic acid and Clinically Isolated CNS Demyelinating Syndrome
| Article | Year |
|---|---|
Temporal and spatial evolution of various functional neurons during demyelination induced by cuprizone.
Topics: Animals; Astrocytes; Axons; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glutamic Acid; Mice; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Myelin Sheath; Neurons | 2021 |
Glutamate delta-1 receptor regulates oligodendrocyte progenitor cell differentiation and myelination in normal and demyelinating conditions.
Topics: Animals; Cell Differentiation; Corpus Callosum; Cuprizone; Demyelinating Diseases; Glutamic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin Sheath; Oligodendrocyte Precursor Cells; Oligodendroglia; Receptors, Glutamate | 2023 |
Signal alterations of glutamate-weighted chemical exchange saturation transfer MRI in lysophosphatidylcholine-induced demyelination in the rat brain.
Topics: Animals; Brain; Demyelinating Diseases; Glutamic Acid; Lysophosphatidylcholines; Magnetic Resonance Imaging; Male; Rats; Rats, Wistar | 2020 |
Temporal Changes in In Vivo Glutamate Signal during Demyelination and Remyelination in the Corpus Callosum: A Glutamate-Weighted Chemical Exchange Saturation Transfer Imaging Study.
Topics: Administration, Oral; Animals; Axons; Brain; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glutamic Acid; Immunohistochemistry; Magnetic Resonance Imaging; Male; Microscopy, Electron, Transmission; Myelin Sheath; Rats; Rats, Sprague-Dawley; Remyelination | 2020 |
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Topics: Amino Acid Transport System X-AG; Animals; Blotting, Western; Brain; Cells, Cultured; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Fluorescent Antibody Technique; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Protein Array Analysis; Real-Time Polymerase Chain Reaction; Receptors, Glutamate; Signal Transduction | 2013 |
Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination.
Topics: Animals; Bacterial Toxins; Calcium; Cells, Cultured; Cerebellum; Clostridium perfringens; Demyelinating Diseases; Glutamic Acid; Oligodendroglia; Rats | 2015 |
HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage.
Topics: Active Transport, Cell Nucleus; Animals; Axons; Brain; Cell Nucleus; Cells, Cultured; Cuprizone; Demyelinating Diseases; Exportin 1 Protein; Glutamic Acid; Histone Deacetylase 1; Humans; Karyopherins; Mice; Mice, Inbred C57BL; Mitochondria; Multiple Sclerosis; Neurons; Rats; Receptors, Cytoplasmic and Nuclear; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.
Topics: Animals; Cardiovirus Infections; Cell Death; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Demyelinating Diseases; Fluorescent Antibody Technique; Glutamic Acid; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Microscopy, Confocal; Multiple Sclerosis; Oligodendroglia; Organ Culture Techniques; Spinal Cord; Theilovirus | 2010 |
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Child; Choline; Contrast Media; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Image Enhancement; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2011 |
White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indicates demyelination or increased myelin turnover rather than dysmyelination.
Topics: Aspartic Acid; Brain Diseases; Choline; Chromosome Deletion; Chromosomes, Human, Pair 18; Demyelinating Diseases; Female; Follow-Up Studies; Glutamic Acid; Humans; Infant; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Myelin Sheath | 2005 |
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.
Topics: Amino Acid Transport System X-AG; Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Cell Death; Cells, Cultured; Demyelinating Diseases; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Neurotoxins; Oligodendroglia; Oligodeoxyribonucleotides, Antisense; Optic Nerve Diseases; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Wallerian Degeneration | 2005 |
Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
Topics: Aged; Amino Acid Substitution; Central Nervous System Diseases; Charcot-Marie-Tooth Disease; Connexins; Demyelinating Diseases; Electromyography; Female; Gap Junction beta-1 Protein; Glutamic Acid; HeLa Cells; Humans; Leucine; Male; Middle Aged; Mutation, Missense; Neural Conduction; Pedigree; Phenotype; Polyneuropathies; Proline; Sural Nerve; Valine | 2006 |
Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Echo-Planar Imaging; Female; Glutamic Acid; Humans; Lactic Acid; Male; Middle Aged; Multiple Sclerosis; Protons | 2007 |
Leukoencephalopathy upon disruption of the chloride channel ClC-2.
Topics: Age Factors; Animals; Axons; Blood-Brain Barrier; Brain; Brain Diseases; Canavan Disease; Chloride Channels; CLC-2 Chloride Channels; Demyelinating Diseases; Epilepsy; Glutamic Acid; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Mutation; Myelin Sheath; RNA, Complementary; Subcellular Fractions; Time Factors; Up-Regulation; Vacuoles | 2007 |
Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Topics: Adult; Aged; Cerebral Cortex; Demyelinating Diseases; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Female; Glial Fibrillary Acidic Protein; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Male; Microglia; Middle Aged; Multiple Sclerosis; Neurons; Postmortem Changes; Synapses | 2007 |
Novel peak assignments of in vivo (13)C MRS in human brain at 1.5 T.
Topics: Adult; Aspartic Acid; Bicarbonates; Brain; Carbon Isotopes; Child, Preschool; Creatine; Demyelinating Diseases; Electron Spin Resonance Spectroscopy; Female; Glucose; Glutamic Acid; Glutamine; Humans; Infusions, Intravenous; Inositol; Magnetic Resonance Spectroscopy; Male; Occipital Lobe; Taurine | 2000 |
[Oligodendroglial exocytosis y demyelination in the optic nerve].
Topics: Animals; Cell Death; Demyelinating Diseases; Exocytosis; Glutamic Acid; Humans; Kainic Acid; Models, Animal; Oligodendroglia; Optic Nerve; Rabbits; Receptors, AMPA | 2000 |
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phosphocreatine; Severity of Illness Index | 2001 |